Literature DB >> 19443047

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.

Luisa M Villar1, Thomas Masterman, Bonaventura Casanova, José Gómez-Rial, Mercedes Espiño, María C Sádaba, Pedro González-Porqué, Francisco Coret, José C Alvarez-Cermeño.   

Abstract

Oligoclonal IgG bands (OCGB) are characteristic of multiple sclerosis (MS). Most patients show OCGB exclusively in cerebrospinal fluid (CSF). Others have serum bands with additional ones in CSF. Moreover, IgM bands against myelin lipids (LS-OCMB) associate with aggressive relapsing-remitting MS (RRMS). We studied oligoclonal bands in 424 MS patients. Most primary progressive (PPMS) patients showed serum OCGB with additional bands in CSF. Conversely, most RRMS and secondary progressive (SPMS) patients showed OCGB exclusively in CSF (p<0.0001). Moreover, no PPMS patient presented LS-OCMB, while 31% of RRMS and 60% of SPMS groups showed these antibodies (p<0.0001). This suggests heterogeneous autoimmune mechanisms in MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443047     DOI: 10.1016/j.jneuroim.2009.03.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association.

Authors:  G Bigliardi; J Mandrioli; F Valzania; P Nichelli; N Casula; A M Simone; P Sola
Journal:  Neurol Sci       Date:  2010-06-29       Impact factor: 3.307

2.  Evaluating the Role of HLA DRB1 Alleles and Oligoclonal Bands in Influencing Clinical Course of Multiple Sclerosis - A Study from the Mangalore Demyelinating Disease Registry.

Authors:  Anitha DCunha; Lekha Pandit; Chaithra Malli; Akshatha Sudhir
Journal:  Ann Indian Acad Neurol       Date:  2021-01-11       Impact factor: 1.383

Review 3.  Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.

Authors:  Francisco J Quintana; Ada Yeste; Howard L Weiner; Ruxandra Covacu
Journal:  J Neuroimmunol       Date:  2012-05-12       Impact factor: 3.478

4.  No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.

Authors:  Madlyne Becker; Clotilde Latarche; Emilie Roman; Marc Debouverie; Catherine Malaplate-Armand; Francis Guillemin
Journal:  BMC Neurol       Date:  2015-05-13       Impact factor: 2.474

Review 5.  Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.

Authors:  Mickael Bonnan
Journal:  Mult Scler Int       Date:  2015-01-08

6.  Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.

Authors:  Gabriele Farina; Roberta Magliozzi; Marco Pitteri; Richard Reynolds; Stefania Rossi; Alberto Gajofatto; Maria Donata Benedetti; Francesco Facchiano; Salvatore Monaco; Massimiliano Calabrese
Journal:  J Neuroinflammation       Date:  2017-02-21       Impact factor: 8.322

7.  Comparison of disease activity in SPMS and PPMS in the context of multicenter clinical trials.

Authors:  Rotem Orbach; Zhenming Zhao; Yong-Cheng Wang; Gilmore O'Neill; Diego Cadavid
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

8.  Quantified CSF antibody reactivity against myelin in multiple sclerosis.

Authors:  Xingwen Sun; Mostafa Bakhti; Dirk Fitzner; Mareike Schnaars; Niels Kruse; Ünal Coskun; Christiane Kremser; Klaus Willecke; Ludwig Kappos; Jens Kuhle; Mikael Simons
Journal:  Ann Clin Transl Neurol       Date:  2015-11-09       Impact factor: 4.511

9.  Serum antibodies to phosphatidylcholine in MS.

Authors:  Maria Cruz Sádaba; Veit Rothhammer; Úrsula Muñoz; Cristina Sebal; Esther Escudero; Pia Kivisäkk; Maria Isabel Garcia Sanchez; Guillermo Izquierdo; Stephen L Hauser; Sergio E Baranzini; Jorge R Oksenberg; Roberto Álvarez-Lafuente; Rohit Bakshi; Howard L Weiner; Francisco J Quintana
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-06-09

10.  Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study.

Authors:  Natasa Giedraitiene; Egle Drukteiniene; Rasa Kizlaitiene; Andrius Cimbalas; Rimvydas Asoklis; Gintaras Kaubrys
Journal:  Front Neurol       Date:  2021-07-13       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.